Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,440 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07883070Recruiting
Screening for anxiety and depression in blood cancer patients
This study looks at how common anxiety and depression are in people with blood cancers. It uses questionnaires to screen your mood, which may help your care team support you better.
Xiamen, FujianAges Any age - NCT06589596RecruitingPhase 1
BGB-58067 alone or with other drugs for advanced solid tumors
This study tests an experimental drug, BGB-58067, which may block a protein that helps cancer cells grow. It's for people with advanced solid tumors that have a specific genetic change (MTAP loss). The drug may be given alone or with other anti-cancer drugs.
Los Alamitos, CaliforniaAges 18 years+ - NCT07882394Recruiting
Alpha-lipoic acid as an add-on to gum treatment for gingivitis
This trial tests whether adding alpha-lipoic acid (an antioxidant) to standard non-surgical gum treatment helps reduce gingivitis (gum inflammation) better than the standard treatment alone. It aims to see if the combination is more effective for gum health.
IstanbulAges 18–65 - NCT07801300RecruitingPhase 1
Study of a new medicine for inflammation
This study tests a new medicine called LY5625575 to see how safe it is and how the body handles it. It is for healthy people and also for people with mild inflammation, which is measured by a blood test.
Miami, FloridaAges 18–65 - NCT07883720Recruiting
Exercise effects on brain health in neurological diseases
This study looks at how exercise might change the body and brain in people with certain neurological disorders compared to healthy people. If you join, you may do some exercise tests and MRI scans, which could help us learn how to improve brain health.
Boston, MassachusettsAges 18 years+ - NCT07875478Recruiting
Tracking health and treatment for people with factor X deficiency
This study collects information from people with factor X deficiency and their family members to better understand how the condition affects people over time. It may help improve future care and treatment.
FlorenceAges Any age - NCT07881965RecruitingPhase 3
WS016 for lowering high potassium
This study tests an investigational medicine called WS016 to see if it can safely lower high potassium levels in the blood. High potassium can be dangerous, and this treatment may offer a new option to help manage it.
Anqing, AnhuiAges 18 years+ - NCT07883044Recruiting
Gut bacteria supplement for mild Crohn's disease
This trial tests a specially formulated supplement (sodium propionate) to see if it can improve the balance of bacteria in your gut, which may help control Crohn's disease. It's for people with mild or inactive Crohn's who want to explore a new way to support their gut health.
PadovaAges 18–75 - NCT06089161Recruiting
Personalized sleep apnea treatment for Black adults
This study tests whether personalized treatment for obstructive sleep apnea (OSA) can improve memory and thinking and lower Alzheimer's disease risk in Black adults.
Miami, FloridaAges 55–85 - NCT07365319RecruitingPhase 2/Phase 3
New drug combo for stage 4 lung cancer
This trial tests a new drug called EIK1001 combined with standard immunotherapy (pembrolizumab) and chemotherapy for people with stage 4 non-small cell lung cancer who have not been treated before. The goal is to see if adding EIK1001 helps shrink tumors more than the current standard treatment.
Daphne, AlabamaAges 18 years+ - NCT07604571RecruitingPhase 1
Testing IEV407 for Advanced Hormone-Sensitive Breast Cancer
This study tests a new drug called IEV407, either alone or combined with existing hormone therapies, in people with advanced breast cancer that is hormone-receptor positive and HER2 negative. The trial aims to find the right dose and see if this combination helps people whose cancer has stopped responding to previous treatments.
New Haven, ConnecticutAges 18 years+ - NCT07646847Recruiting
A support program for people with cancer on immunotherapy
This study tests a program that helps people with cancer manage side effects and find resources for needs like food, transportation, or housing. It is for patients who are starting or recently started immunotherapy for certain cancers.
Basking Ridge, New JerseyAges 18 years+ - NCT07731880Recruiting
SmartMatch Study for Rare Gynecologic Cancers
This study tests a new approach called SmartMatch that looks at the unique traits of your tumor to find the best treatment for you. The goal is to see if this personalized approach is feasible and helpful for people with rare gynecologic cancers.
Seattle, WashingtonAges 18 years+ - NCT07756645RecruitingPhase 3
Study of a new drug with chemotherapy for advanced lung cancer
This study tests a new drug called ABBV-1480 combined with chemotherapy for people with a type of lung cancer called squamous non-small cell lung cancer that has spread or cannot be removed with surgery. The goal is to see if it works as well as or better than the current standard treatment, pembrolizumab (also known as Keytruda) with chemotherapy.
Fort Wayne, IndianaAges 18 years+ - NCT06607458RecruitingPhase 2
Liver-focused chemo for metastatic colorectal cancer
This trial tests giving high-dose melphalan directly into the liver's blood supply, followed by standard cancer therapy, for people whose colorectal cancer has spread mainly to the liver. The goal is to see if this approach is safer and works better than standard treatment alone.
Duarte, CaliforniaAges 18 years+ - NCT07099898RecruitingPhase 3
Study of a new drug for relapsed small cell lung cancer
This study tests a new drug (GSK5764227) for people whose extensive-stage small cell lung cancer has gotten worse after platinum chemotherapy combined with immunotherapy. The goal is to see if this targeted treatment can help shrink tumors and control the cancer.
Los Angeles, CaliforniaAges 18 years+ - NCT07359846RecruitingPhase 3
Add-on treatment for severe uncontrolled asthma
This study tests a new add-on medicine called GB-0895 for people with severe asthma that is not well controlled with current treatments. It aims to see if adding this medicine can reduce asthma attacks and improve breathing.
Bakersfield, CaliforniaAges 12–80 - NCT04921943RecruitingPhase 4
Hypertonic saline to treat MAC lung infection
This trial tests whether inhaled hypertonic saline can improve symptoms and lung health in people with a specific lung infection called MAC. It targets adults with confirmed MAC infection and bronchiectasis who are not already on certain MAC medications.
New York, New YorkAges 18 years+ - NCT07504458RecruitingPhase 3
Study of QTX-2101 for adults with a type of leukemia
This trial tests a new drug, QTX-2101, in people with acute promyelocytic leukemia (APL) that is low- or intermediate-risk. The study aims to see if the drug works and is safe for those who qualify.
Birmingham, AlabamaAges 18–71 - NCT06994143RecruitingPhase 1
A study of CLN-978 for rheumatoid arthritis
This trial tests a new medicine called CLN-978, given as an injection under the skin, to see if it can help people with active rheumatoid arthritis who haven't improved enough with other treatments. CLN-978 works by targeting a specific immune cell to reduce inflammation.
ErlangenAges 18 years+ - NCT07227597RecruitingPhase 1/Phase 2
Study of two experimental drugs for advanced small cell lung cancer
This study tests two experimental drugs, gocatamig and ifinatamab deruxtecan, for people with advanced small cell lung cancer. The goal is to see if this combination can help control the cancer, either as a first treatment or after initial standard therapy.
Santa Rosa, CaliforniaAges 18 years+ - NCT07601074RecruitingPhase 2
Testing DARE-HPV to Clear Persistent HPV Infection
This study tests whether DARE-HPV, a new treatment, can help your body clear a persistent human papillomavirus (HPV) infection that hasn't gone away on its own. HPV is a common virus; persistent infection with certain high-risk types can lead to cervical cancer, so clearing it early may prevent future problems.
Phoenix, ArizonaAges 22–50 - NCT07468695Recruiting
Comparing one vs two heat treatments for cervical precancer in Kenya
This study tests whether using one or two heat probes is better at removing precancerous cells from the cervix in women living with HIV. It aims to find a simpler, effective way to treat cervical precancer and prevent cancer.
NairobiAges 25–49 - NCT06873945RecruitingPhase 3
Study of two doses of ritlecitinib for alopecia areata
This study tests two different doses of a pill called ritlecitinib to see if it can help regrow hair in people with significant hair loss from alopecia areata. It is for people aged 12 and older who have lost at least half of their scalp hair.
Birmingham, AlabamaAges 12 years+
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,440 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.